Alzheimer's Research and Therapy
SJR Rank #988H-index: 123SJR: 2.479Best quartile: Q1Open AccessAPC: US$4,290Listed in DOAJ
Journal website: aims, scope and author guidelinesPublisher
BioMed Central Ltd
Country
United Kingdom
Type
journal
SJR by Edition
Subject Categories
- Cognitive NeuroscienceQ1
- NeurologyQ1
- Neurology (clinical)Q1
Areas: Medicine · Neuroscience
Most published research topics
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsFunctional Brain Connectivity StudiesNeuroinflammation and Neurodegeneration MechanismsIntracerebral and Subarachnoid Hemorrhage ResearchNeurological Disease Mechanisms and TreatmentsCholinesterase and Neurodegenerative DiseasesAmyotrophic Lateral Sclerosis ResearchCancer-related cognitive impairment studiesParkinson's Disease Mechanisms and Treatments
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
1758-9193
SJR Best Quartile
Q1
Region
Western Europe
Citations per Document (2 years)
7.82
References per Document
58.83
Coverage
2010-2026
Scope
Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.
Metrics from SCImago Journal Rank 2025. View on SCImago